Islam E. Elkholi

516 total citations
17 papers, 347 citations indexed

About

Islam E. Elkholi is a scholar working on Molecular Biology, Cell Biology and Cancer Research. According to data from OpenAlex, Islam E. Elkholi has authored 17 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Cell Biology and 6 papers in Cancer Research. Recurrent topics in Islam E. Elkholi's work include Cancer, Hypoxia, and Metabolism (3 papers), Cellular transport and secretion (3 papers) and Hemoglobin structure and function (3 papers). Islam E. Elkholi is often cited by papers focused on Cancer, Hypoxia, and Metabolism (3 papers), Cellular transport and secretion (3 papers) and Hemoglobin structure and function (3 papers). Islam E. Elkholi collaborates with scholars based in Canada, United States and Egypt. Islam E. Elkholi's co-authors include Jean‐François Côté, Morag Park, Marie-Anne Goyette, Jean‐Philippe Gratton, Marwan Emara, Magdi H. Yacoub, Jonathan Boulais, Denis Faubert, Ibrahim M. El‐Sherbiny and Amélie Robert and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Islam E. Elkholi

16 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Islam E. Elkholi Canada 9 172 86 76 54 45 17 347
Iratxe Zuazo-Gaztelu United States 5 173 1.0× 99 1.2× 82 1.1× 55 1.0× 62 1.4× 6 321
Amanda L. Bain Australia 12 261 1.5× 47 0.5× 93 1.2× 36 0.7× 43 1.0× 19 382
Sandra Bien-Möller Germany 12 235 1.4× 52 0.6× 108 1.4× 47 0.9× 87 1.9× 19 403
Qin Zhao China 11 295 1.7× 45 0.5× 74 1.0× 48 0.9× 104 2.3× 27 487
Hee Yeon Kim South Korea 12 284 1.7× 64 0.7× 55 0.7× 28 0.5× 121 2.7× 22 432
Dominique Arsenault Canada 7 278 1.6× 98 1.1× 84 1.1× 23 0.4× 86 1.9× 8 440
Vassilis Papalazarou United Kingdom 11 196 1.1× 149 1.7× 84 1.1× 30 0.6× 104 2.3× 13 412
Wade H. Aaron United States 8 178 1.0× 60 0.7× 109 1.4× 44 0.8× 55 1.2× 18 404
Hung‐Chi Cheng Taiwan 9 292 1.7× 55 0.6× 116 1.5× 87 1.6× 78 1.7× 15 455
Anja Bastian United States 12 188 1.1× 29 0.3× 97 1.3× 29 0.5× 64 1.4× 14 357

Countries citing papers authored by Islam E. Elkholi

Since Specialization
Citations

This map shows the geographic impact of Islam E. Elkholi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Islam E. Elkholi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Islam E. Elkholi more than expected).

Fields of papers citing papers by Islam E. Elkholi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Islam E. Elkholi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Islam E. Elkholi. The network helps show where Islam E. Elkholi may publish in the future.

Co-authorship network of co-authors of Islam E. Elkholi

This figure shows the co-authorship network connecting the top 25 collaborators of Islam E. Elkholi. A scholar is included among the top collaborators of Islam E. Elkholi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Islam E. Elkholi. Islam E. Elkholi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Elkholi, Islam E., Amélie Robert, Jia Wu, et al.. (2025). Targeting the Dependence on PIK3C3-mTORC1 Signaling in Dormancy-Prone Breast Cancer Cells Blunts Metastasis Initiation. Cancer Research. 85(12). 2179–2198. 1 indexed citations
2.
Elkholi, Islam E., et al.. (2025). High Ki-67 expression is associated with increased risk of distant recurrence in Oncotype Dx low risk breast cancer. Clinical Breast Cancer. 25(6). e690–e696.e1. 1 indexed citations
3.
Elkholi, Islam E., Shannon A. Fraser, Marco Biondini, et al.. (2025). Exploring the efficacy and mechanism of action of combined pan-Raf and MEK inhibition in halting the growth of non-V600 BRAF mutated tumors.. Journal of Clinical Oncology. 43(16_suppl). 3117–3117.
4.
Elkholi, Islam E., April A. N. Rose, Julio A. Aguirre‐Ghiso, & Jean‐François Côté. (2024). How can we integrate the biology of breast cancer cell dormancy into clinical practice?. Cancer Cell. 42(7). 1147–1151. 4 indexed citations
5.
Elkholi, Islam E., Jonathan Boulais, Marie‐Pier Thibault, et al.. (2023). Mapping the MOB proteins’ proximity network reveals a unique interaction between human MOB3C and the RNase P complex. Journal of Biological Chemistry. 299(9). 105123–105123. 3 indexed citations
6.
Elkholi, Islam E., et al.. (2022). Breast Cancer Metastatic Dormancy and Relapse: An Enigma of Microenvironment(s). Cancer Research. 82(24). 4497–4510. 26 indexed citations
7.
Elkholi, Islam E., et al.. (2022). Interphase microtubule disassembly is a signaling cue that drives cell rounding at mitotic entry. The Journal of Cell Biology. 221(6). 10 indexed citations
8.
Elkholi, Islam E., Marwa E. Elsherbiny, & Marwan Emara. (2022). Myoglobin: From physiological roles to potential implications in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1877(3). 188706–188706. 21 indexed citations
9.
Goyette, Marie-Anne, Islam E. Elkholi, Hellen Kuasne, et al.. (2021). Targeting Axl favors an antitumorigenic microenvironment that enhances immunotherapy responses by decreasing Hif-1α levels. Proceedings of the National Academy of Sciences. 118(29). 51 indexed citations
10.
Elsherbiny, Marwa E., et al.. (2021). Expression of Myoglobin in Normal and Cancer Brain Tissues: Correlation With Hypoxia Markers. Frontiers in Oncology. 11. 590771–590771. 7 indexed citations
11.
Elkholi, Islam E., Somayyeh Fahiminiya, Suzanna L. Arcand, et al.. (2021). Investigating the causal role of MRE11A p.E506* in breast and ovarian cancer. Scientific Reports. 11(1). 2409–2409. 4 indexed citations
12.
Abu-Thuraia, Afnan, Islam E. Elkholi, Rui Chen, et al.. (2020). Shedding of cancer susceptibility candidate 4 by the convertases PC7/furin unravels a novel secretory protein implicated in cancer progression. Cell Death and Disease. 11(8). 665–665. 15 indexed citations
13.
Elkholi, Islam E., et al.. (2020). Myoglobin variants are expressed in human glioblastoma cells‑hypoxia effect?. Oncology Reports. 43(3). 975–985. 6 indexed citations
14.
Bagci, Halil, Amélie Robert, Jonathan Boulais, et al.. (2019). Mapping the proximity interaction network of the Rho-family GTPases reveals signalling pathways and regulatory mechanisms. Nature Cell Biology. 22(1). 120–134. 110 indexed citations
15.
Goyette, Marie-Anne, Islam E. Elkholi, Afnan Abu-Thuraia, et al.. (2019). AXL knockdown gene signature reveals a drug repurposing opportunity for a class of antipsychotics to reduce growth and metastasis of triple-negative breast cancer. Oncotarget. 10(21). 2055–2067. 38 indexed citations
16.
El‐Sherbiny, Ibrahim M., Islam E. Elkholi, & Magdi H. Yacoub. (2014). Tissue plasminogen activator-based clot busting: Controlled delivery approaches. Global Cardiology Science and Practice. 2014(3). 46–46. 28 indexed citations
17.
Elkholi, Islam E.. (2014). Evaluation of Anti-Cancer Potential of Capsaicin-Loaded Trimethyl Chitosan-Based Nanoparticles in HepG2 Hepatocarcinoma Cells. Journal of Nanomedicine & Nanotechnology. 5(6). 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026